Jaguar Health, INC Form 4 insider transactions

Director John Micek of Jaguar Health, Inc. was granted stock options for 26,500 shares of common stock on October 8, 2024.

James Bochnowski, a director at Jaguar Health, was granted stock options to purchase 23,200 shares of common stock on October 8, 2024.

Anula Jayasuriya, a director of Jaguar Health, Inc., was granted 21,000 stock options on October 8, 2024, according to a Form 4 filing with the SEC.

Steven R. King, a Jaguar Health executive, reports the acquisition of common stock and stock options, according to a Form 4 filing.

Jonathan B. Siegel, a director of Jaguar Health, Inc., was granted stock options to purchase 26,500 shares of common stock on October 8, 2024.

Pravin R Chaturvedi, Chief Scientific Officer of Jaguar Health, Inc., reports the vesting and conversion of restricted stock units into common stock.

Jonathan S. Wolin, Chief of Staff, CCO & GC of Jaguar Health, Inc., reported the vesting of restricted stock units into common stock on May 17, 2024.

Carol R. Lizak, CFO of Jaguar Health, Inc., reports the vesting and conversion of restricted stock units into common stock.

Steven R. King, a Jaguar Health executive, reported the vesting and conversion of restricted stock units into common stock on May 17, 2024.

Lisa Conte, CEO of Jaguar Health, reports the conversion of restricted stock units into common stock.

Pravin R. Chaturvedi, Chief Scientific Officer of Jaguar Health, Inc., acquired 134 shares of common stock on April 5, 2024, through the vesting of restricted stock units.

Jonathan S. Wolin, Chief of Staff, CCO & GC of Jaguar Health, Inc., reported the acquisition and disposal of common stock and restricted stock units on April 5, 2024.

Carol R. Lizak, CFO of Jaguar Health, reports changes in her beneficial ownership of company stock due to the vesting of restricted stock units.

Steven R. King, an executive at Jaguar Health, reported the acquisition and disposal of common stock and restricted stock units on April 5, 2024.

Lisa Conte, CEO and President of Jaguar Health, reports the acquisition and disposal of common stock and restricted stock units.